Infermedica

What is Infermedica and who sells it?

Infermedica describes "clinical AI triage that gets patients to the right care by chat, voice, or call center", deployed across 30 or more countries since 2012 (Infermedica website, October 2026). The company is in Wroclaw, Poland, and was founded in 2012 by Piotr Orzechowski (CEO), Irving Loh and Roberto Sicconi. A $30M Series B closed on 26 January 2022, led by One Peak with Karma Ventures, EBRD, Heal Capital and Inovo, bringing total funding to about $45M (Infermedica blog, One Peak).

What does it do?

Use cases are call center and nurse triage, digital front door triage and pre-visit intake. A Call Center Voice Agent collects symptoms, assesses acuity and prepares a structured handoff. Developers can use a Triage API and an Intake API (Infermedica website and developer portal). The vendor claims cost-to-savings ratios of up to 1 to 10 in national deployments, and the home page cites no study for it.

Infermedica's Intake API page says clinicians can transfer diagnoses and notes into the EHR. A listing on the AVIA marketplace, written by the vendor, names Epic and Cerner. Epic integration is not documented, and BAA availability is not stated.

What is its regulatory status?

The Medical Guidance Platform, covering Triage, Intake and Follow-up, is certified as a Class IIb medical device under the EU MDR and is registered with the UK MHRA. Earlier versions of Triage and Intake were Class I in the EU. Brazil's ANVISA registration is in place, Australian TGA registration is in progress, and EU AI Act work is listed as in progress (Infermedica regulatory page).

For the US, the vendor says its software "operates under FDA enforcement discretion" as a symptom questionnaire that guides the care setting. Infermedica has no entry in the FDA 510(k) database. Security attestations listed are ISO 27001:2022, ISO 13485:2016, SOC 2 Type 2 and GDPR, and the vendor says it complies with HIPAA.

What does the evidence say?

A 2026 prospective trial in the Western Journal of Emergency Medicine (PMID 42054141) randomized 18,000 adults equally to Infermedica-supported triage, the Emergency Severity Index or the Manchester Triage System. It took place in a single emergency department, so it says little about call center use.

A systematic review of symptom checkers tested Symptomate, Infermedica's older consumer checker. Top-3 diagnostic accuracy was 27.5% and safe advice was given 97.8% of the time (PMC9385087). The same review puts triage accuracy across symptom checkers at 48.8% to 90.1%. Infermedica also hosts its own studies on its research page.

How much does Infermedica cost?

Infermedica sells by enterprise quote, and the site's call to action is "Schedule an intro" (October 2026).

How does it compare?

Ada Health is the usual rival in symptom-checker studies. Others in the same category include Buoy Health, K Health, Mediktor, Hyro, Hippocratic AI, Ubie Health and Clearstep. Infermedica's distinguishing point is the Class IIb certification.

The verdict

A European payer or hospital group that needs certified triage logic should shortlist Infermedica. A US buyer should ask for the FDA position and a US customer reference first, and walk away if neither is concrete.